Menu

Parkinson’s Researcher Notches 17 Retracted Papers

Scientific misconduct motivated Yoshihiro Sato’s three additional retractions last month; his institution doesn’t respond. 

Sep 13, 2017
Aggie Mika

ISTOCK, ALLANSWARTUpdate (December 7, 2017): According to Retraction Watch, Sato’s retraction count is now up to 23 and Hirosaki University, where Sato was based from 2000 to 2003, confirmed in November that a number of Sato’s papers were compromised by fake data, plagiarism, or authorship issues.

Yoshihiro Sato, a researcher from Mitate Hospital in Tagawa, Japan, cited scientific wrongdoing when he asked the Journal of Neurology, Neurosurgery, and Psychiatry to pull three of his publications, adding to his list of 14 prior retractions, Retraction Watch reports.

The journal announced its investigation in May and retracted Sato’s three papers last month. According to the retraction notices, Sato told the journal editors that he didn’t have his coauthors’ permission to include them on the papers and that the authors in question didn’t contribute to the published science.

“Despite repeated requests for further explanation, we have not received any response from Dr Sato’s institution,” read the journal’s retraction notices

The now-disputed research involves randomized human studies testing various therapeutics for ailments associated with Parkinson’s Disease. The most-cited study of the three, published in 1999, garnered 79 citations and reported that a form of vitamin D could lessen the risk for bone fractures in Parkinson’s patients with low bone density. The other two studies were published in 2003 and 2011 and cited 28 and eight times, respectively, reports Retraction Watch.

In addition to the mounting list of retractions, more of Sato’s papers have recently come under fire. Last year, a group of researchers investigated the validity of 33 human trials that list Sato as an author and determined that the studies were suspect.

“Our analysis suggests that the results of at least some of these trials are not reliable,” investigation coauthor Mark Bolland of the University of Auckland told Across America Patch in 2016. “In addition, results from these trials were not consistent with results found in similar studies by other researchers.”

The journals that retracted Sato’s work in the past report a laundry list of reasons, ranging from plagiarism to authorship mishaps, notes the Retraction Watch report.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.